India-focused venture capital firm Helion Venture Partners has invested INR350 million (approximately US$6.5 million) in LifeCell International, an India-based stem cell bank. LifeCell preserves stem cells from various human tissues and provides services including bedside stem cell processing and newborn screening at 110 locations in India and abroad. Helion’s investment is intended to increase LifeCell’s market penetration in India and enable the development of new cell-based therapies.